mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
0.0002 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0002 |